Detalhe da pesquisa
1.
Pralsetinib in patients with RET fusion-positive non-small-cell lung cancer: A plain language summary of the ARROW study.
Future Oncol
; 20(6): 297-306, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37916501